- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 138797, 10 pages
doi:10.1155/2012/138797
Human L-Ficolin (Ficolin-2) and Its Clinical Significance
1Scottish National Blood Transfusion Service, National Science Laboratory, Ellen’s Glen Road, Edinburgh EH17 7QT, UK
2MRC Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK
Received 15 September 2011; Accepted 14 November 2011
Academic Editor: Misao Matsushita
Copyright © 2012 David C. Kilpatrick and James D. Chalmers. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
David C. Kilpatrick and James D. Chalmers, “Human L-Ficolin (Ficolin-2) and Its Clinical Significance,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 138797, 10 pages, 2012. doi:10.1155/2012/138797